Skip to content

Improvement of skin diseases in obese patients after weight loss surgery and its mechanism

Improvement of skin diseases in obese patients after weight loss surgery and its mechanism

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042716
Enrollment
Unknown
Registered
2021-01-26
Start date
2021-01-26
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin disease

Interventions

1:Bariatric surgery

Sponsors

Xiangya Third Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged from 20 to 60 years old (including 20 and 60 years old); 2. The subjects whose body mass index (BMI) is above 27.5 kg / m2, whose lifestyle changes and medical treatment are difficult to control, meet at least two diagnostic criteria of metabolic syndrome, or have other complications; 3. Women of childbearing age should use an effective method for contraception at least one month before screening, and agree to use this method for contraception during the study period and at least one year after surgery; 4. Waist circumference >= 90cm for male and >= 85CM for female; 5. Patients with skin diseases, including acanthosis nigricans, psoriasis, acne or hirsutism, etc; 6. Patients or guardians fully understand that this is a clinical trial and voluntarily participate in it. They are willing to return visit within the specified time to assist in the completion of the trial.

Exclusion criteria

Exclusion criteria: All subjects who meet one of the following conditions can not be included in the trial: 1. Subjects with a history of drug and / or alcohol abuse within 2 years; Those with mental retardation and uncontrollable behavior; 2. Subjects who are unwilling to cooperate with the changes of diet and living habits after operation; 3. Patients with severe kidney disease, uncontrolled hypertension (>= 150 / 100mmhg), symptomatic ischemic heart disease, cerebral infarction or arteriosclerosis obliterans, malignant tumor, poor general condition, difficult to tolerate general anesthesia and surgery; 4. Patients with previous gastrointestinal surgery (such as surgery involving gastrointestinal resection), or invasive medical intervention, such as colonoscopy, 3 months before sampling (feces); The diet changed significantly one week before sampling; Female in physiological stage; Patients with other intestinal inflammatory diseases (such as ulcerative colitis, Crohn's disease, etc.); Use oral antibiotics or probiotics within 3 months. 5. Patients who the researchers think are not suitable for participation.

Design outcomes

Primary

MeasureTime frame
Skin CT and skin pathology: thickness of stratum corneum and spinous layer, degree of inflammatory cell infiltration, distribution and density of melanocytes, etc.;

Secondary

MeasureTime frame
Obesity: BMI, waist-to-hip ratio, %EWL, etc.; Type 2 diabetes: ADA diabetes relief criteria; other metabolic indicators: blood sugar, blood lipids, blood pressure, inflammatory factors, and intestinal hormones.;

Countries

China

Contacts

Public ContactZhu Shaihong

Xiangya Third Hospital of Central South University

shaihongzhu@126.com+86 18975186193

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026